Drug-Repositioning Screens Identify Triamterene as a Selective Drug for the Treatment of DNA Mismatch Repair Deficient Cells

View/Open
Volume
23
Pagination
2880 - 2890
DOI
10.1158/1078-0432.CCR-16-1216
Journal
CLINICAL CANCER RESEARCH
Issue
11
ISSN
1078-0432
Metadata
Show full item record
Authors
Guillotin, D; Austin, P; Begum, R; Freitas, MO; Merve, A; Brend, T; Short, S; Marino, S; Martin, SA
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/19059
Collections
Copyright statements
(c) The Author(s) 2016.